European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention

Archive ouverte

Stratigos, Alexander John | Garbe, Claus | Dessinioti, Clio | Lebbe, Célèste | Bataille, Véronique | Bastholt, Lars | Dreno, Brigitte | Fargnoli, Maria Concetta | Forsea, Ana Maria | Frenard, Cecille | Harwood, Catherine Anne | Hauschild, Axel | Hoeller, Christoph | Kandolf-Sekulovic, Lidija | Kaufmann, Roland | Kelleners-Smeets, Nicole W.J. | Malvehy, Josep | del Marmol, Véronique | Middleton, Mark R. | Moreno-Ramirez, David | Pellecani, Giovanni | Peris, Ketty | Saiag, Phillippe | van den Beuken-van Everdingen, Marieke H.J. | Vieira, Ricardo | Zalaudek, Iris | Eggermont, Alexander M.M. | Grob, Jean Jacques

Edité par CCSD ; Elsevier -

International audience. Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated in cSCC etiopathogenesis include ultraviolet radiation exposure and chronic photoaging, age, male sex, immunosuppression, smoking and genetic factors. A collaboration of multidisciplinary experts from the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation of Research and Treatment of Cancer (EORTC) was formed to update recommendations on cSCC classification, diagnosis, risk stratification, staging and prevention, based on current literature, staging systems and expert consensus. Common cSCCs are typically indolent tumors, and most have a good prognosis with 5-year cure rates of greater than 90%, and a low rate of metastases (<4%). Further risk stratification into low-risk or high-risk common primary cSCC is recommended based on proposed high-risk factors. Advanced cSCC is classified as locally advanced (lacSCC), and metastatic (mcSCC) including locoregional metastatic or distant metastatic cSCC. Current systems used for staging include the American Joint Committee on Cancer (AJCC) 8th edition, the Union for International Cancer Control (UICC) 8th edition, and Brigham and Women's Hospital (BWH) system. Physical examination for all cSCCs should include total body skin examination and clinical palpation of lymph nodes, especially of the draining basins. Radiologic imaging such as ultrasound of the regional lymph nodes, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography–computed tomography (PET-CT) scans are recommended for staging of high-risk cSCC. Sentinel lymph node biopsy is currently not recommended. Nicotinamide, oral retinoids, and topical 5-FU have been used for the chemoprevention of subsequent cSCCs in high-risk patients but are not routinely recommended. Education about sun protection measures including reducing sun exposure, use of protective clothing, regular use of sunscreens and avoidance of artificial tanning, is recommended.

Consulter en ligne

Suggestions

Du même auteur

European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment

Archive ouverte | Stratigos, Alexander John | CCSD

International audience. In order to update recommendations on treatment, supportive care, education and follow-up of patients with invasive cutaneous squamous cell carcinoma (cSCC), a multidisciplinary panel of expe...

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019

Archive ouverte | Garbe, Claus | CCSD

International audience. A unique collaboration of multidisciplinary experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization for Research and Treatment ...

The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC Cutaneous Lymphoma Task Force

Archive ouverte | Garbe, Claus | CCSD

International audience. Background: The incidence of skin cancers has been increasing steadily over the last decades. Although there have been significant breakthroughs in the management of skin cancers with the int...

Chargement des enrichissements...